logo

For the Inventor, By the Inventor

Watertown, MA, United States of America

Tetraphase Pharmaceuticals, Inc.


USPTO Granted Patents = 17



Trademarks = 6

Forward Citations = 91

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Xiao-Yi Xiao (12 out of 35 patents)

silverMedal Roger B Clark (11 out of 21 patents)

bronzeMedal Minsheng He (11 out of 24 patents)

4.  Louis Plamondon (9 out of 28 patents)

5.  Magnus Ronn (7 out of 11 patents)

6.  Diana Katharine Hunt (7 out of 7 patents)

7.  Cuixiang Sun (6 out of 7 patents)

8.  Danny LaFrance (5 out of 5 patents)

9.  Chi-Li Chen (5 out of 9 patents)

10.  Wu-Yan Zhang (5 out of 5 patents)

11.  Jingye Zhou (4 out of 17 patents)

12.  Magnus Rönn (4 out of 4 patents)

13.  Robert Zahler (3 out of 74 patents)

14.  Philip C Hogan (3 out of 3 patents)

15.  Yansheng Liu (3 out of 3 patents)


17 patents:

1. 12269807 - Crystalline forms of eravacycline (2025-04-08),
2. 11578044 - Crystalline forms of eravacycline (2023-02-14),
3. 10961190 - Crystalline forms of eravacycline (2021-03-30),
4. 10913712 - Tetracycline compounds (2021-02-09),
5. 10618879 - Semi-synthesis procedures (2020-04-14),
6. 10315992 - Tetracyline compounds (2019-06-11),
7. 10087157 - Semi-synthesis procedures (2018-10-02),
8. 10072007 - Tetracycline compounds (2018-09-11),
9. 9624166 - Tetracycline compounds (2017-04-18),
10. 9573895 - Tetracycline compounds (2017-02-21),
11. 9371283 - Polycyclic tetracycline compounds (2016-06-21),
12. 9315451 - Tetracycline compounds (2016-04-19),
13. 8906887 - C7-fluoro substituted tetracycline compounds (2014-12-09),
14. 8828988 - 8-AZA tetracycline compounds (2014-09-09),
15. 8796245 - C7-fluoro substituted tetracycline compounds (2014-08-05),
Tetraphase Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel antibiotics for the treatment of serious and life-threatening infections. With a robust pipeline of potential products, Tetraphase is committed to addressing the growing global health threat of antibiotic resistance. Their innovative approach combines chemistry and microbiology to create potent, differentiated antibiotics that target drug-resistant bacteria. Leveraging their expertise, Tetraphase aims to improve patient outcomes and contribute to the fight against antibiotic resistance.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

17 Patents

#22 in Watertown, MA

#1,106 in Massachusetts

#18,334 in US

#34,861 in the World

...
Watertown, MA, United States of America

Tetraphase Pharmaceuticals, Inc.

Forward Citations = 91

19 inventors:

goldMedal Xiao-Yi Xiao (12 out of 35 patents)

silverMedal Roger B Clark (11 out of 21 patents)

bronzeMedal Minsheng He (11 out of 24 patents)

4.  Louis Plamondon (9 out of 28 patents)

5.  Magnus Ronn (7 out of 11 patents)

Please report any incorrect information to support@idiyas.com
Loading…